2023

Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167)

2022

Atout, S., Shurrab, S. and Loveridge, C. (2022) Evaluation of the suitability of RNAscope as a technique to measure gene expression in clinical diagnostics: a systematic review. Molecular Diagnosis and Therapy, 26(1), pp. 19-37. (doi: 10.1007/s40291-021-00570-2) (PMID:34957535)

2021

Honeychurch, S. , Soler, L. , Price, V. , Loveridge, C., Docherty, F. , Tasler, N. , Dickson, B. and Pope, L. (2021) The Power of Collaborative SoTL. [Website]

Dickson, B. , Docherty, F., Honeychurch, S. , Jamieson, S. , Loveridge, C., Pope, L. , Price, V. , Soler, L. and Tasler, N. (2021) SoTL 'Unconference'. 14th Annual Learning & Teaching Conference: Transforming Teaching & Taking Stock, Glasgow, Scotland, United Kingdom, 18 June 2021. (Unpublished)

Dickson, B. , Docherty, F. , Honeychurch, S. , Loveridge, C., Pope, L. , Price, V. , Soler, L. and Tasler, N. (2021) Getting Started with SoTL. 15th Annual University of Glasgow Learning & Teaching Conference Pre-Conference Workshop, 21 Mar 2022.

2020

Patel, R. et al. (2020) Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer. Cancer Research, 80(3), pp. 576-590. (doi: 10.1158/0008-5472.CAN-19-1684) (PMID:31719098)

Loveridge, C. (2020) My SoTL interests, University of Glasgow SoTL Advent Calendar. [Website]

Loveridge, C. J. et al. (2020) BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration. Oncogene, 39, pp. 1797-1806. (doi: 10.1038/s41388-019-1106-x) (PMID:31740786) (PMCID:PMC7033044)

2018

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi: 10.15252/emmm.201708347) (PMID:29540470) (PMCID:PMC5887544)

2017

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi: 10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

Loveridge, C. J. et al. (2017) Increased T cell infiltration elicited by Erk5 deletion in a Pten-deficient mouse model of prostate carcinogenesis. Cancer Research, 77(12), pp. 3158-3168. (doi: 10.1158/0008-5472.CAN-16-2565) (PMID:28515147)

2016

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi: 10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

2015

Loveridge, C., Mui, E., Ahmad, I. , Welsh, M., Tan, E., Fleming, J., Sansom, O. and Leung, H. (2015) The Role of Erk5 in Prostate Carcinogenesis. In: 11th World Congress on Urological Research, Nijmegen, The Nertherlands, September 2015, (Unpublished)

Articles

Rushworth, L. K. et al. (2023) Phase II proof of concept study of atorvastatin in castration resistant prostate cancer. BJU International, 131(2), pp. 236-243. (doi: 10.1111/bju.15851) (PMID:35844167)

Atout, S., Shurrab, S. and Loveridge, C. (2022) Evaluation of the suitability of RNAscope as a technique to measure gene expression in clinical diagnostics: a systematic review. Molecular Diagnosis and Therapy, 26(1), pp. 19-37. (doi: 10.1007/s40291-021-00570-2) (PMID:34957535)

Patel, R. et al. (2020) Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer. Cancer Research, 80(3), pp. 576-590. (doi: 10.1158/0008-5472.CAN-19-1684) (PMID:31719098)

Loveridge, C. J. et al. (2020) BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration. Oncogene, 39, pp. 1797-1806. (doi: 10.1038/s41388-019-1106-x) (PMID:31740786) (PMCID:PMC7033044)

Patel, R. et al. (2018) Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10(4), e8347. (doi: 10.15252/emmm.201708347) (PMID:29540470) (PMCID:PMC5887544)

Loveridge, C. J. et al. (2017) Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity. Scientific Reports, 7, 13241. (doi: 10.1038/s41598-017-13346-8) (PMID:29038439) (PMCID:PMC5643304)

Loveridge, C. J. et al. (2017) Increased T cell infiltration elicited by Erk5 deletion in a Pten-deficient mouse model of prostate carcinogenesis. Cancer Research, 77(12), pp. 3158-3168. (doi: 10.1158/0008-5472.CAN-16-2565) (PMID:28515147)

Ahmad, I. et al. (2016) Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 113(29), pp. 8290-8295. (doi: 10.1073/pnas.1601571113) (PMID:27357679) (PMCID:PMC4961202)

Conference or Workshop Item

Dickson, B. , Docherty, F., Honeychurch, S. , Jamieson, S. , Loveridge, C., Pope, L. , Price, V. , Soler, L. and Tasler, N. (2021) SoTL 'Unconference'. 14th Annual Learning & Teaching Conference: Transforming Teaching & Taking Stock, Glasgow, Scotland, United Kingdom, 18 June 2021. (Unpublished)

Dickson, B. , Docherty, F. , Honeychurch, S. , Loveridge, C., Pope, L. , Price, V. , Soler, L. and Tasler, N. (2021) Getting Started with SoTL. 15th Annual University of Glasgow Learning & Teaching Conference Pre-Conference Workshop, 21 Mar 2022.

Conference Proceedings

Loveridge, C., Mui, E., Ahmad, I. , Welsh, M., Tan, E., Fleming, J., Sansom, O. and Leung, H. (2015) The Role of Erk5 in Prostate Carcinogenesis. In: 11th World Congress on Urological Research, Nijmegen, The Nertherlands, September 2015, (Unpublished)

Website

Honeychurch, S. , Soler, L. , Price, V. , Loveridge, C., Docherty, F. , Tasler, N. , Dickson, B. and Pope, L. (2021) The Power of Collaborative SoTL. [Website]

Loveridge, C. (2020) My SoTL interests, University of Glasgow SoTL Advent Calendar. [Website]